Prostate Cancer Clinical Trials in Austin

Showing 121-140 of 210 trials

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

NCT05010759

Stage 2B: NanoTherm ablation of focal prostate cancer in small lesions in Gleason 3+4 disease. The outcome of this ablation is validated by a transperineal biopsy at 4 months after ablation.

Prostate Cancer

MagForce USA3 participantsStarted Nov 2021

Tampa, Florida, United States • Austin, Texas, United States • San Antonio, Texas, United States +1 more locations

COMPLETED< 1 mile

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

NCT05447637

This registry is for men who have prostate cancer and have had multigene panel hereditary testing. The registry will gather data on genetic testing results and how that information may change physician treatment or follow up recommendations. It will also gather data on the patient's experience with genetic testing, through a post-test survey to be completed 60-90days after results have been received and discussed with their provider.

Prostate Cancer

Invitae Corporation1,000 participantsStarted Nov 2019

San Diego, California, United States • San Francisco, California, United States • San Francisco, California, United States +16 more locations

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Prostate Cancer Trials in Other Cities

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

Radiation Therapy in Treating Patients With Prostate Cancer

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Other Conditions in Austin